Meeting
2021 ASCO Annual Meeting
Genetic assessment of hereditary breast and ovarian cancer in the Harris Health System: A five-year, single-center experience.
Authors
Nicole Higashiyama
Lester and Sue Smith Breast Center, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX
Nicole Higashiyama , Shaun Bulsara , Susan G. Hilsenbeck , Tiffaney Tran , Ria Brown , Mary Fang , Cathy Sullivan , Georgiann Garza , C. Kent Osborne , Mothaffar F. Rimawi , Julie R. Nangia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10587)
DOI
10.1200/JCO.2021.39.15_suppl.10587
Abstract #
10587
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Impact of pre-surgical germline multigene panel testing on choice of surgery for breast cancer.
First Author: Elena Zarcaro
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2022 ASCO Annual Meeting
Cascade testing of first-degree relatives of patients with pancreatic cancer with confirmed germline genetic mutations: A simulation modeling study.
First Author: Mary Linton Bounetheau Peters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares